Lates News

Prime Medicine (PRME.US): The Q1 financial report for 2025 achieved revenue of $1.454 million, up from $0.591 million in the previous period, and higher than the expected value of $3.43 million; earnings per share were -$0.40, an improvement from -$0.44 in the previous period, but lower than the expected value of -$0.31.